Previous 10 | Next 10 |
Aptose Biosciences (NASDAQ: APTO ): Q4 GAAP EPS of -$0.13 misses by $0.01 . More news on: Aptose Biosciences Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
SAN DIEGO and TORONTO, March 10, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, today announc...
SAN DIEGO and TORONTO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, will release its financial results for the quarter and year ende...
Ballard Power Systems (NASDAQ: BLDP ) -15% . More news on: Ballard Power Systems Inc., DPW Holdings, Inc., Plug Power Inc., Stocks on the move, , Read more ...
Bolstered by new data presented at a key medical conference, Aptose Biosciences 's (NASDAQ: APTO) stock bolted skyward in December, more than doubling in price. Savvy investors looking for exposure to the high-risk, high-reward biotech sector need to look no further. Image source: ...
The following slide deck was published by Aptose Biosciences Inc. in conjunction with this Read more ...
SAN DIEGO and TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that the company will host a key opinion leader ...
These Penny Stocks Are Soaring This Month; Are You Watching? It’s always fun to write about penny stocks that are trading at lower levels only to see them go on explosive runs afterward. Since our redesign, PennyStocks.com has focused on following the biggest trends, best penny stocks...
The following slide deck was published by Aptose Biosciences Inc. in conjunction with this Read more ...
Aptose Biosciences (APS CN) initiated with Overweight rating at Piper Sandler. Shares up 2% premarket in U.S. (NASDAQ: APTO ). More news on: Aptose Biosciences Inc., BioDelivery Sciences International, Inc., BiomX Inc., Healthcare stocks news, Stocks on the move, , Read mor...
News, Short Squeeze, Breakout and More Instantly...
Aptose Biosciences Inc. Company Name:
APTO Stock Symbol:
NASDAQ Market:
Aptose Biosciences Inc. Website:
SAN DIEGO and TORONTO, July 19, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, t...
SAN DIEGO and TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies,...
TUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid Leukemia (AML) and Differentiate TUS from other Investigational Drugs in AML TUS Monotherapy and TUS+VEN Doublet Therapy Active in...